 Connection
Frederick Masoudi to Heart Diseases
This is a "connection" page, showing publications Frederick Masoudi has written about Heart Diseases.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.704 |
|
|
|
-
Peterson PN, Magid DJ, Ross C, Ho PM, Rumsfeld JS, Lauer MS, Lyons EE, Smith SS, Masoudi FA. Association of exercise capacity on treadmill with future cardiac events in patients referred for exercise testing. Arch Intern Med. 2008 Jan 28; 168(2):174-9.
Score: 0.211
-
Havranek EP, Masoudi FA. What we're talking about when we talk about race. J Am Coll Cardiol. 2004 Feb 04; 43(3):436-7.
Score: 0.160
-
Kini V, Dayoub EJ, Hess PL, Marzec LN, Masoudi FA, Ho PM, Groeneveld PW. Clinical Outcomes After Cardiac Stress Testing Among US Patients Younger Than 65 Years. J Am Heart Assoc. 2018 03 10; 7(6).
Score: 0.106
-
Curtis JP, Geary LL, Wang Y, Chen J, Drye EE, Grosso LM, Spertus JA, Rumsfeld JS, Weintraub WS, Masoudi FA, Brindis RG, Krumholz HM. Development of 2 registry-based risk models suitable for characterizing hospital performance on 30-day all-cause mortality rates among patients undergoing percutaneous coronary intervention. Circ Cardiovasc Qual Outcomes. 2012 Sep 01; 5(5):628-37.
Score: 0.073
-
Miller AL, Wang Y, Curtis J, Masoudi FA, Buxton AE, Wang TY. Optimal medical therapy use among patients receiving implantable cardioverter/defibrillators: insights from the National Cardiovascular Data Registry. Arch Intern Med. 2012 Jan 09; 172(1):64-7.
Score: 0.069
-
Jones DW, Peterson ED, Bonow RO, Masoudi FA, Fonarow GC, Smith SC, Solis P, Girgus M, Hinton PC, Leonard A, Gibbons RJ. Translating research into practice for healthcare providers: the American Heart Association's strategy for building healthier lives, free of cardiovascular diseases and stroke. Circulation. 2008 Aug 05; 118(6):687-96.
Score: 0.054
-
O'Meara E, McDonald M, Chan M, Ducharme A, Ezekowitz JA, Giannetti N, Grzeslo A, Heckman GA, Howlett JG, Koshman SL, Lepage S, Mielniczuk LM, Moe GW, Swiggum E, Toma M, Virani SA, Zieroth S, De S, Matteau S, Parent MC, Asgar AW, Cohen G, Fine N, Davis M, Verma S, Cherney D, Abrams H, Al-Hesayen A, Cohen-Solal A, D'Astous M, Delgado DH, Desplantie O, Estrella-Holder E, Green L, Haddad H, Harkness K, Hernandez AF, Kouz S, LeBlanc MH, Lee D, Masoudi FA, McKelvie RS, Rajda M, Ross HJ, Sussex B. CCS/CHFS Heart Failure Guidelines: Clinical Trial Update on Functional Mitral Regurgitation, SGLT2 Inhibitors, ARNI in HFpEF, and Tafamidis in Amyloidosis. Can J Cardiol. 2020 02; 36(2):159-169.
Score: 0.030
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|